Use of Pressure Muscle Index to Avoid Over-assistance During Pressure Support Ventilation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jian-Xin Zhou, MD
- Phone Number: 8610 59978019
- Email: zhoujx.cn@icloud.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100070
- Recruiting
- Beijing Tiantan Hospital
-
Contact:
- Yan-Lin Yang, MD
-
Beijing, Beijing, China, 100029
- Recruiting
- China-Japan Friendship Hospital
-
Contact:
- De-Jing Song, BS
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mechanical ventilated patients within 48 hours after the transition from a controlled mode to PSV
Exclusion Criteria:
- History of neuromuscular disease
- History of diaphragm dysfunction and surgery
- History of esophageal, gastric or lung surgery
- Decreased level of consciousness
- Central respiratory drive dysfunction
- Considered withholding of life support
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Inspiratory support level with PMI equal to -2
PMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
|
Inspiratory support is the pressure delivered by the ventilator during pressure support ventilation.
|
|
Experimental: Inspiratory support level with PMI equal to 0
PMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
|
Inspiratory support is the pressure delivered by the ventilator during pressure support ventilation.
|
|
Experimental: Inspiratory support level with PMI equal to +2
PMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
|
Inspiratory support is the pressure delivered by the ventilator during pressure support ventilation.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inspiratory effort
Time Frame: 30 minutes
|
Inspiratory effort is measured as pressure generated by inspiratory muscles using esophageal pressure monitoring.
|
30 minutes
|
|
Work of breathing
Time Frame: 30 minutes
|
Work of breathing is measured by the Campbell diagram and pressure-time-product using esophageal pressure monitoring.
|
30 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory system compliance (ml/cmH2O)
Time Frame: 30 minutes
|
Respiratory system compliance is calculated as the ratio between tidal volume and driving pressure.
|
30 minutes
|
|
Partial pressure of oxygen in arterial blood (mmHg)
Time Frame: Partial pressure of oxygen in arterial blood
|
Partial pressure of oxygen in arterial blood is obtained by blood gas analysis.
|
Partial pressure of oxygen in arterial blood
|
|
Partial pressure of carbon dioxide in arterial blood (mmHg)
Time Frame: 30 minutes
|
Partial pressure of carbon dioxide in arterial blood is obtained by blood gas analysis.
|
30 minutes
|
|
Respiratory rate (breaths/min)
Time Frame: 30 minutes
|
Respiratory rate calculation includes ineffective trigger.
|
30 minutes
|
|
Tidal volume (ml)
Time Frame: 30 minutes
|
Tidal volume is obtained by intergation of flow-time tracing.
|
30 minutes
|
|
Rapid shallow breathing index
Time Frame: 30 minutes
|
Rapid shallow breathing index is calculated as the ratio between respiratory rate and tidal volume.
|
30 minutes
|
|
The use of accessory respiratory muscle
Time Frame: 30 minutes
|
The use of accessory respiratory muscle is observed at the bedside.
|
30 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- KY2021-012-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.